Cascade Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cascade Investment Advisors's LLY Position: Q3 2024 in Review
Cascade Investment Advisors sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 325 shares — an estimated $294K sold.
Cascade Investment Advisors first reported a position in LLY in Q2 2018 and held it in 22 quarters. The position peaked at $294K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Cascade Investment Advisors reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
- Cascade Investment Advisors sold 325 Eli Lilly shares in Q3 2024, an estimated $294K.
- Cascade Investment Advisors first reported a position in Eli Lilly in Q2 2018 and held it in 22 quarters.
- Cascade Investment Advisors's Eli Lilly position peaked at $294K in Q2 2024.
- 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Cascade Investment Advisors's 13F filing for Q3 2024, filed 2 Oct 2024.